Norah Arafeh is an associate in the Mergers and Acquisitions Group, and is resident in the New York office.
Norah represents domestic and international buyers and sellers in private and public domestic, cross-border and global mergers and acquisitions, restructurings, joint ventures and private investments in a broad range of industries.
Prior to law school, she was a U.S. Fulbright Scholar in Amman, Jordan.
Representation of Helix Acquisition Corp. (NASDAQ: HLXA), a SPAC, in its US$230 million business combination with MoonLake Immunotherapeutics AG, a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory skin and joint diseases.
Representation of FSN Capital Fund IV in its sale of Active Brands, house of premium outdoor sports apparel and equipment brands (including Kari Traa, Sweet Protection, Johaug, Dæhlie, Bula, Åsnes and Vossatassar) to FSN Capital Fund VI and Verdane.
Representation of Anthem, Inc. in its acquisition of myNEXUS Inc., a post-acute benefits management company focused on delivering innovative home and community-based product offerings.